NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $498 | +60.1% | 4,897 | +58.6% | 0.05% | +19.5% |
| Q2 2023 | $311 | +9.1% | 3,088 | -0.4% | 0.04% | -2.4% |
| Q1 2023 | $285 | +2.2% | 3,100 | +0.6% | 0.04% | -8.7% |
| Q4 2022 | $279 | -99.9% | 3,083 | 0.0% | 0.05% | +2.2% |
| Q3 2022 | $234,000 | -10.0% | 3,083 | 0.0% | 0.04% | -6.2% |
| Q2 2022 | $260,000 | -3.7% | 3,083 | 0.0% | 0.05% | +9.1% |
| Q1 2022 | $270,000 | +6.7% | 3,083 | +0.5% | 0.04% | -51.1% |
| Q1 2020 | $253,000 | -12.5% | 3,067 | +0.5% | 0.09% | -6.2% |
| Q4 2019 | $289,000 | +9.1% | 3,052 | 0.0% | 0.10% | -4.0% |
| Q3 2019 | $265,000 | -99.9% | 3,052 | 0.0% | 0.10% | -5.7% |
| Q2 2019 | $278,678,000 | +95011.9% | 3,052 | 0.0% | 0.11% | -12.4% |
| Q1 2019 | $293,000 | +7.3% | 3,052 | -4.1% | 0.12% | -9.7% |
| Q4 2018 | $273,000 | – | 3,183 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |